Current management of lupus nephritis

被引:44
作者
Houssiau, Frederic A. [1 ]
Lauwerys, Bernard R. [1 ]
机构
[1] Catholic Univ Louvain, Inst Rech Expt & Clin, Clin Univ St Luc, Pole & Serv Rhumatol, B-1200 Brussels, Belgium
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2013年 / 27卷 / 03期
关键词
Lupus nephritis; Treatment; Immunosuppression; Optimal care; STAGE RENAL-DISEASE; TERM-FOLLOW-UP; MYCOPHENOLATE-MOFETIL; CONTROLLED-TRIAL; INTRAVENOUS CYCLOPHOSPHAMIDE; DOUBLE-BLIND; IMMUNOSUPPRESSIVE THERAPY; INDUCTION THERAPY; ORAL STEROIDS; ERYTHEMATOSUS;
D O I
10.1016/j.berh.2013.07.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite decades of clinical research aimed at finding the most appropriate immunosuppressive regime, lupus nephritis (LN) remains one of the major disease manifestations of systemic lupus erythematosus (SLE) with a great impact on survival and quality of life. We start this review by defining the disease burden, the real-world challenges and the poor prognostic factors. We then discuss the current anti-inflammatory, cytotoxic and biologic therapies, with special emphasis on the need for optimal global care. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:319 / 328
页数:10
相关论文
共 40 条
  • [1] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
    Appel, Gerald B.
    Contreras, Gabriel
    Dooley, Mary Anne
    Ginzler, Ellen M.
    Isenberg, David
    Jayne, David
    Li, Lei-Shi
    Mysler, Eduardo
    Sanchez-Guerrero, Jorge
    Solomons, Neil
    Wofsy, David
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 1103 - 1112
  • [2] THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS
    AUSTIN, HA
    KLIPPEL, JH
    BALOW, JE
    LERICHE, NGH
    STEINBERG, AD
    PLOTZ, PH
    DECKER, JL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) : 614 - 619
  • [3] Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
    Bertsias, George K.
    Tektonidou, Maria
    Amoura, Zahir
    Aringer, Martin
    Bajema, Ingeborg
    Berden, Jo H. M.
    Boletis, John
    Cervera, Ricard
    Doerner, Thomas
    Doria, Andrea
    Ferrario, Franco
    Floege, Juergen
    Houssiau, Frederic A.
    Ioannidis, John P. A.
    Isenberg, David A.
    Kallenberg, Cees G. M.
    Lightstone, Liz
    Marks, Stephen D.
    Martini, Alberto
    Moroni, Gabriela
    Neumann, Irmgard
    Praga, Manuel
    Schneider, Matthias
    Starra, Argyre
    Tesar, Vladimir
    Vasconcelos, Carlos
    van Vollenhoven, Ronald F.
    Zakharova, Helena
    Haubitz, Marion
    Gordon, Caroline
    Jayne, David
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1771 - 1782
  • [4] CONTROLLED TRIAL OF PULSE METHYLPREDNISOLONE VERSUS 2 REGIMENS OF PULSE CYCLOPHOSPHAMIDE IN SEVERE LUPUS NEPHRITIS
    BOUMPAS, DT
    AUSTIN, HA
    VAUGHN, EM
    KLIPPEL, JH
    STEINBERG, AD
    YARBORO, CH
    BALOW, JE
    [J]. LANCET, 1992, 340 (8822) : 741 - 745
  • [5] Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
    Cervera, R
    Khamashta, MA
    Font, J
    Sebastiani, GD
    Gil, A
    Lavilla, P
    Mejía, JC
    Aydintug, AC
    Chwalinska-Sadowska, H
    de Ramón, E
    Fernández-Nebro, A
    Galeazzi, M
    Valen, M
    Mathieu, A
    Houssiau, FD
    Caro, N
    Alba, P
    Ramos-Casals, M
    Ingelmo, M
    Hughes, GRV
    [J]. MEDICINE, 2003, 82 (05) : 299 - 308
  • [6] Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
    Chambers, Sharon A.
    Allen, Elizabeth
    Rahman, Anisur
    Isenberg, David
    [J]. RHEUMATOLOGY, 2009, 48 (06) : 673 - 675
  • [7] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    Chan, TM
    Li, FK
    Tang, CSO
    Wong, RWS
    Fang, GX
    Ji, YL
    Lau, CS
    Wong, AKM
    Tong, MKL
    Chan, KW
    Lai, KN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16) : 1156 - 1162
  • [8] Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
    Condon, Marie B.
    Ashby, Damien
    Pepper, Ruth J.
    Cook, H. Terence
    Levy, Jeremy B.
    Griffith, Megan
    Cairns, Tom D.
    Lightstone, Liz
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (08) : 1280 - 1286
  • [9] Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
    Costedoat-Chalumeau, Nathalie
    Amoura, Zahir
    Hulot, Jean-Sebastien
    Aymard, Guy
    Leroux, Gaelle
    Marra, Donata
    Lechat, Philippe
    Piette, Jean-Charles
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (06) : 821 - 824
  • [10] Trends in the Incidence, Demographics, and Outcomes of End-Stage Renal Disease Due to Lupus Nephritis in the US From 1995 to 2006
    Costenbader, Karen H.
    Desai, Amrita
    Alarcon, Graciela S.
    Hiraki, Linda T.
    Shaykevich, Tamara
    Brookhart, M. Alan
    Massarotti, Elena
    Lu, Bing
    Solomon, Daniel H.
    Winkelmayer, Wolfgang C.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (06): : 1681 - 1688